These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 8496302

  • 1. Reduced expression of glucocorticoid receptor levels in human osteoarthritic chondrocytes. Role in the suppression of metalloprotease synthesis.
    DiBattista JA, Martel-Pelletier J, Antakly T, Tardif G, Cloutier JM, Pelletier JP.
    J Clin Endocrinol Metab; 1993 May; 76(5):1128-34. PubMed ID: 8496302
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal human chondrocytes.
    DiBattista JA, Martel-Pelletier J, Wosu LO, Sandor T, Antakly T, Pelletier JP.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):316-26. PubMed ID: 1846871
    [Abstract] [Full Text] [Related]

  • 3. Modulation of glucocorticoid receptor expression in human articular chondrocytes by cAMP and prostaglandins.
    DiBattista JA, Martel-Pelletier J, Cloutier JM, Pelletier JP.
    J Rheumatol Suppl; 1991 Feb; 27():102-5. PubMed ID: 1851225
    [Abstract] [Full Text] [Related]

  • 4. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP.
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [Abstract] [Full Text] [Related]

  • 5. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation.
    Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J.
    Osteoarthritis Cartilage; 1996 Mar; 4(1):77-84. PubMed ID: 8731398
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization in osteoarthritic chondrocytes.
    Orfanidou T, Malizos KN, Varitimidis S, Tsezou A.
    Exp Biol Med (Maywood); 2012 Mar; 237(3):241-53. PubMed ID: 22393163
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
    Hirose J, Ryan LM, Masuda I.
    Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
    [Abstract] [Full Text] [Related]

  • 11. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta.
    Kaiser M, Haag J, Söder S, Bau B, Aigner T.
    Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348
    [Abstract] [Full Text] [Related]

  • 12. Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells.
    Tardif G, Pelletier JP, Dupuis M, Geng C, Cloutier JM, Martel-Pelletier J.
    Arthritis Rheum; 1999 Jun; 42(6):1147-58. PubMed ID: 10366107
    [Abstract] [Full Text] [Related]

  • 13. Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4.
    Olney RC, Tsuchiya K, Wilson DM, Mohtai M, Maloney WJ, Schurman DJ, Smith RL.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1096-103. PubMed ID: 8772582
    [Abstract] [Full Text] [Related]

  • 14. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K, Ohta S, Matsumoto T, Fujimoto N, Sato H, Seiki M, Okada Y.
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro.
    Bobacz K, Gruber R, Soleiman A, Erlacher L, Smolen JS, Graninger WB.
    Arthritis Rheum; 2003 Sep; 48(9):2501-8. PubMed ID: 13130469
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes.
    Shlopov BV, Smith GN, Cole AA, Hasty KA.
    Arthritis Rheum; 1999 Apr; 42(4):719-27. PubMed ID: 10211886
    [Abstract] [Full Text] [Related]

  • 19. Identification in human osteoarthritic chondrocytes of proteins binding to the novel regulatory site AGRE in the human matrix metalloprotease 13 proximal promoter.
    Fan Z, Tardif G, Boileau C, Bidwell JP, Geng C, Hum D, Watson A, Pelletier JP, Lavigne M, Martel-Pelletier J.
    Arthritis Rheum; 2006 Aug; 54(8):2471-80. PubMed ID: 16868967
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.